XENE Operating Cash Flow (Statement)
Xenon Pharmaceuticals Inc · Operating Cash Flow (Statement)
XENE Operating Cash Flow (Statement)
Latest reported-$337.52Mperiod ending
XENE Cash from Operations (-$13.69M → -$337.52M)
Annual operating cash flow (statement)
High-resolution chart · PNG
XENE operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -279,118,000 | |
| -181,389,000 | |
| -145,327,000 | |
| -98,430,000 | |
| -69,502,000 | |
| -48,124,000 | |
| -4,632,000 | |
| -34,724,000 | |
| -28,726,000 | |
| -19,567,000 | |
| -18,103,000 | |
| 266,000 | |
| -3,322,000 | |
| 45,573,000 | |
| -13,689,000 |